A Versatile Strategy for Screening Custom-Designed Warhead-Armed Cyclic Peptide Inhibitors

Angew Chem Int Ed Engl. 2023 Feb 6;62(7):e202214815. doi: 10.1002/anie.202214815. Epub 2023 Jan 12.

Abstract

Demand for peptide-based pharmaceuticals has been steadily increasing, but only limited success has been achieved to date. To expedite peptide-based drug discovery, we developed a general scheme for cell-based screening of cyclic peptide inhibitors armed with a user-designed warhead. We combined unnatural amino acid incorporation and split intein-mediated peptide cyclization techniques and integrated a yeast-based colorimetric screening assay to generate a new scheme that we call the custom-designed warhead-armed cyclic peptide screening platform (CWCPS). This strategy successfully discovered a potent inhibitor, CY5-6Q, that targets human histone deacetylase 8 (HDAC8) with a KD value of 15 nM. This approach can be a versatile and general platform for discovering cyclic peptide inhibitors.

Keywords: Cyclic Peptide Inhibitor; Genetic Code Expansion; Warhead-Bearing Unnatural Amino Acid.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acids / metabolism
  • Histone Deacetylase Inhibitors
  • Histone Deacetylases / metabolism
  • Humans
  • Inteins
  • Peptides* / chemistry
  • Peptides, Cyclic* / chemistry
  • Protein Splicing
  • Repressor Proteins / metabolism

Substances

  • Peptides, Cyclic
  • Peptides
  • Amino Acids
  • Histone Deacetylase Inhibitors
  • HDAC8 protein, human
  • Histone Deacetylases
  • Repressor Proteins